Portosystemic shunt surgery in patients with ıdiopathic noncirrhotic portal hypertension

dc.authorid131278en_US
dc.authorid149014en_US
dc.authorid149014en_US
dc.authorid31153en_US
dc.authorid131819en_US
dc.authorid109262en_US
dc.authorid110105en_US
dc.contributor.authorKaragül, Servet
dc.contributor.authorYağcı, Mehmet Ali
dc.contributor.authorTardu, Ali
dc.contributor.authorErtuğrul, İsmail
dc.contributor.authorKırmızı, Serdar
dc.contributor.authorSümer, Fatih
dc.contributor.authorIşık, Burak
dc.contributor.authorKayaalp, Cüneyt
dc.contributor.authorYılmaz, Sezai
dc.date.accessioned2017-11-06T08:30:00Z
dc.date.available2017-11-06T08:30:00Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.descriptionAnn Transplant, 2016; 21: 317-320en_US
dc.description.abstractBackground: Idiopathic noncirrhotic portal hypertension (INCPH) is a rare disease characterized by increased portal venous pressure in the absence of cirrhosis and other causes of liver diseases. The aim of the present study was to present our results in using portosystemic shunt surgery in patients with INCPH. Material/Methods: Patients who had been referred to our Liver Transplantation Institute for liver transplantation and who had undergone surgery from January 2010 to December 2015 were retrospectively analyzed. Patients with INCPH who had undergone portosystemic shunt procedure were included in the study. Age, sex, symptoms and findings, type of portosystemic shunt, and postoperative complications were assessed. Results: A total of 1307 patients underwent liver transplantation from January 2010 to December 2015. Eleven patients with INCPH who did not require liver transplantation were successfully operated on with a portosystemic shunt procedure. The mean follow-up was 30.1±19 months (range 7–69 months). There was no mortality in the perioperative period or during the follow-up. Two patients underwent surgery again due to intra-abdominal hemorrhage; one had bleeding from the surgical site except the portacaval anastomosis and the other had bleeding from the h-graft anastomosis. No patient developed encephalopathy and no patient presented with esophageal variceal bleeding after portosystemic shunt surgery. Shunt thrombosis occurred in 1 patient (9.9%). Only 1 patient developed ascites, which was controlled medically. Conclusions: Portosystemic shunt surgery is a safe and effective procedure for the treatment of patients with INCPH. MeSH Keywords: Ascites • Gastrointestinal Hemorrhage • Hypertension, Portal • Liver Transplantation • Portasystemic Shunt, Surgical • Splenorenal Shunt, Surgicalen_US
dc.identifier.citationKaragül, Servet, YAĞCI, M. A., Tardu, Ali, Ertuğrul, İ., Kırmızı, S., SÜMER, F., … YILMAZ, S. (2016). Portosystemic Shunt Surgery İn Patients With Idiopathic Noncirrhotic Portal Hypertension. Annals Of Transplantation, 21, 317–320.en_US
dc.identifier.doi10.12659/AOT.898253en_US
dc.identifier.endpage320en_US
dc.identifier.issue0en_US
dc.identifier.startpage317en_US
dc.identifier.urihttp://www.annalsoftransplantation.com/abstract/index/idArt/898253
dc.identifier.urihttps://hdl.handle.net/11616/7829
dc.identifier.volume21en_US
dc.language.isoenen_US
dc.publisherAnnals of Transplantationen_US
dc.relation.ispartofAnnals of Transplantationen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAscitesen_US
dc.subjectGastrointestinal hemorrhageen_US
dc.subjectHypertension portalen_US
dc.subjectLiver transplantationen_US
dc.subjectPortasystemic shunten_US
dc.subjectSurgicalen_US
dc.subjectSplenorenal shunten_US
dc.subjectSurgicalen_US
dc.titlePortosystemic shunt surgery in patients with ıdiopathic noncirrhotic portal hypertensionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
898253.pdf
Boyut:
173.15 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: